openPR Logo
Press release

Growth Opportunities in Global Vaccines Market

06-19-2019 09:38 AM CET | Health & Medicine

Press release from: DPI Research

DPI Research offers a latest published report on GLobal Vaccines Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global vaccines players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

The global vaccines market size is expected to exceed US$ 48 Billion by the year–end of 2025.

“Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025” presents an in–depth assessment of the global vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for the global vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global vaccines market. The report explores a detailed analysis of the top 42 vaccines market value assessment globally from 2015 to 2018 and forecasts to 2025.

Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration, merger & acquisitions, partnerships, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global vaccines market.

The report concludes with the profiles of major players in the global vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolios, promising vaccines in the clinical development, vaccines market value analysis and recent development.

Long–term Growth Projection:

Merck acquired Immune Design in 2019
Shingrix is set to achieve blockbuster vaccine status in 2019
Prevnar / Prevnar 13 has captured the highest market share of the global vaccines market
With a market value of more than US$ 7 billion, GSK led the global vaccines market in 2018

Top 42 Vaccines Covered Under This Report Are:

Prevnar / Prevnar 13
Gardasil / Gardasil 9
Vaxigrip
Fluzone
Flublok
Varivax
Menactra
Proquad
Pneumovax 23
Fluarix/FluLaval
Havrix/Twinrix/Engerix–B
Priorix, Priorix Tetra, Varilrix
M–M–R II
Adacel
Boostrix
Bexsero
Menveo
Cervarix
Trumenba
Shingrix
Pentacel, Pentaxim, Imovax, Hexaxim
Rotateq
Zostavax
Rotarix
Synflorix
Pediarix,Infanrix
Ticovac
Biken Ha
Tetrabik
Mearubik
Varicella (MTP)
Jebik V
Flumist/Fluenz
Bio Thrax
Dukoral
Ixiaro
In Live
HeaLive
BiLive
Anflu
EasySix
Imvamune

The major companies dominating this market for its products, services, and continuous product developments are:

Sanofi Pasteur
GlaxoSmithKline (GSK)
Merck
Pfizer
AstraZeneca
Mitsubishi Tanabe Pharma
Emergent Biosolutions
Astellas Pharma Inc
Valneva
Seqirus
Bavarian Nordic
Sinovac
Panacea Biotec
Bharat Biotech
Serum Institute of India
Biological E. Limited

The Latest Industry Data Included in this Report:

Global Vaccines Market Size & Analysis (2015 – 2025)
Market Share Analysis of Global Vaccines Market (%),2015 – 2025
Global Vaccines Market Share, By Brand
Global Vaccines Market Share, By Company
Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025
Major Companies Vaccines Market Value Analysis & Forecast
Promising Vaccines in Clinical Development by Major Companies
Detailed Vaccines Portfolio of the Major Companies
Major Deals in the Global Vaccines Market
Key Market Drivers and Inhibitors of the Global Vaccines Market
Major Companies Analysis

The Report Answers the Following Questions about the Global Vaccines Market:

What is the size of the global vaccines market during 2015–2025?
What will be the revenue generated by each vaccine during the forecast period?
Which vaccine provides the highest market share?
What are the leading companies dominating the global vaccines market? What is the share of these companies in the global vaccines market?
How will the industry evolve during the forecast period 2019 – 2025?
What are the key drivers and inhibitors in the current market?
What is the key development implemented by the leading players to stand out in this market?
Who are the key players in this market space?

Key Topics Covered:

1. Executive Summary

2. Global Vaccines Market Size & Analysis (2015 – 2025)

3. Market Share Analysis of Global Vaccines Market (%),2015 – 2025
3.1 Global Vaccines Market Share, By Brand
3.2 Global Vaccines Market Share, By Company

4. Key Drivers and Inhibitors of the Global Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors

5. Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025
5.1 Prevnar / Prevnar 13
5.2 Gardasil / Gardasil 9
5.3 Vaxigrip
5.4 Fluzone
5.5 Flublok
5.6 Varivax
5.7 Menactra
5.8 Proquad
5.9 Pneumovax 23
5.10 Fluarix/FluLaval
5.11 Havrix/Twinrix/Engerix-B
5.12 Priorix, Priorix Tetra, Varilrix
5.13 M-M-R II
5.14 Adacel
5.15 Boostrix
5.16 Bexsero
5.17 Menveo
5.18 Cervarix
5.19 Trumenba
5.20 Shingrix
5.21 Pentacel, Pentaxim, Imovax, Hexaxim
5.22 Rotateq
5.23 Zostavax
5.24 Rotarix
5.25 Synflorix
5.26 Pediarix,Infanrix
5.27 Ticovac
5.28 Biken Ha
5.29 Tetrabik
5.30 Mearubik
5.31 Varicella (MTP)
5.32 Jebik V
5.33 Flumist/Fluenz
5.34 Bio Thrax
5.35 Dukoral
5.36 Ixiaro
5.37 In Live
5.38 HeaLive
5.39 BiLive
5.40 Anflu
5.41 EasySix
5.42 Imvamune
5.43 Other Vaccines

6. Major Deals in Global Vaccines Market
6.1 Merger & Acquisitions
6.2 Collaboration Deal
6.3 Licensing Agreement
6.4 Exclusive Agreement
6.5 Distribution Agreement
6.6 Partnerships

7. Key Companies Analysis
7.1 Sanofi Pasteur
7.1.1 Business Overview
7.1.2 Vaccines Portfolio
7.1.3 Vaccines Market Value Analysis & Forecast
7.1.4 Promising Vaccines in Clinical Development
7.1.5 Recent Development
7.2 GlaxoSmithKline (GSK)
7.2.1 Business Overview
7.2.2 Vaccines Portfolio
7.2.3 Vaccines Market Value Analysis & Forecast
7.2.4 Promising Vaccines in Clinical Development
7.2.5 Recent Development
7.3 Merck
7.3.1 Business Overview
7.3.2 Vaccines Portfolio
7.3.3 Vaccines Market Value Analysis & Forecast
7.3.4 Promising Vaccines in Clinical Development
7.3.5 Recent Development
7.4 Pfizer
7.4.1 Business Overview
7.4.2 Vaccines Portfolio
7.4.3 Vaccines Market Value Analysis & Forecast
7.4.4 Promising Vaccines in Clinical Development
7.4.5 Recent Development
7.5 AstraZeneca
7.5.1 Business Overview
7.5.2 Vaccines Portfolio
7.5.3 Vaccines Market Value Analysis & Forecast
7.5.4 Recent Development
7.6 Mitsubishi Tanabe Pharma
7.6.1 Business Overview
7.6.2 Vaccines Portfolio
7.6.3 Vaccine Market Value Analysis & Forecast
7.6.4 Promising Vaccines in Clinical Development
7.6.5 Recent Development
7.7 Emergent Biosolutions
7.7.1 Business Overview
7.7.2 Vaccines Portfolio
7.7.3 Vaccine Market Value Analysis & Forecast
7.7.4 Promising Vaccines in Clinical Development
7.7.5 Recent Development
7.8 Astlellas Pharma Inc
7.8.1 Business Overview
7.8.2 Vaccines Portfolio
7.8.3 Vaccines Market Value Analysis & Forecast
7.8.4 Recent Development
7.9 Valneva
7.9.1 Business Overview
7.9.2 Vaccines Portfolio
7.9.3 Vaccines Market Value Analysis & Forecast
7.9.4 Promising Vaccines in Clinical Development
7.9.5 Recent Development
7.10 Seqirus
7.10.1 Business Overview
7.10.2 Vaccines Portfolio
7.10.3 Vaccine Market Value Analysis & Forecast
7.10.4 Promising Vaccines in Clinical Development
7.10.5 Recent Development
7.11 Bavarian Nordic
7.11.1 Business Overview
7.11.2 Vaccines Portfolio
7.11.3 Vaccine Market Value Analysis & Forecast
7.11.4 Promising Vaccines in Clinical Development
7.11.5 Recent Development
7.12 Sinovac
7.12.1 Business Overview
7.12.2 Vaccines Portfolio
7.12.3 Vaccine Market Value Analysis & Forecast
7.12.4 Promising Vaccines in Clinical Development
7.12.5 Recent Development
7.13 Panacea Biotec
7.13.1 Business Overview
7.13.2 Vaccines Portfolio
7.13.3 Vaccine Market Value Analysis & Forecast
7.13.4 Promising Vaccines in Clinical Development
7.13.5 Recent Development
7.14 Bharat Biotech
7.14.1 Business Overview
7.14.2 Vaccines Portfolio
7.14.3 Promising Vaccines in Clinical Development
7.14.4 Recent Development
7.15 Serum Institute of India
7.15.1 Business Overview
7.15.2 Vaccines Portfolio
7.15.3 Promising Vaccines in Clinical Development
7.15.4 Recent Development
7.16 Biological E. Limited
7.16.1 Business Overview
7.16.2 Vaccines Portfolio
7.16.3 Promising Vaccines in Clinical Development
7.16.4 Recent Development

Buy this premium research report @https://dpiresearch.com/reports/global-vaccines-market-industry-size-growth-analysis-and-forecast-to-2025/

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report:
DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Maria Rai
Sales Manager
Call: +91 766 764 8693
Email: sales@dpiresearch.com
Full Address:Mehrauli,New Delhi,India,110030
Website: https://dpiresearch.com

DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.

DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growth Opportunities in Global Vaccines Market here

News-ID: 1780419 • Views:

More Releases from DPI Research

China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2032)
China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forec …
China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2032) As per DPI Research latest published report, the China Non-Invasive Prenatal Testing (NIPT) market size was valued at US$ 608 Million in 2023 and it is forecasted to reach US$ 1,083 Million by the year end of 2032. China non invasive prenatal testing (NIPT) market compound annual growth rate will be 7.04% from 2024 to 2032. This new
India Outbound MICE Tourism Market worth US$ 13.4 Billion by 2030|DPI Research
India Outbound MICE Tourism Market worth US$ 13.4 Billion by 2030|DPI Research
DPI Research has published a new research report titled "India Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) Tourism Market 2023: Outlook, Trends, Opportunities and Forecasts to 2031" in its research database. According to the latest research study 2023, India Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) tourism market size is expected to reach US$ 13.4 billion by 2031. The Indian Outbound Tourism (MICE) is experiencing significant growth due to a
India's Outbound Tourism Market Is Expected To Boost By 11% CAGR Between 2023 And 2031: DPI Research Report
India's Outbound Tourism Market Is Expected To Boost By 11% CAGR Between 2023 An …
[230+ Pages Latest Report] According to a market research study published by DPI Research, India's outbound tourism market size is expected to reach $60 billion by 2031, growing at a CAGR of 10.9% over the forecast period 2023-2031. Rising personal income levels and greater accessibility will enable international travel for a greater proportion of India's population. India's sizable global diasporas and international student body will continue to be a pull factor
United States Non Invasive Prenatal Testing (NIPT) Market Size 2023 - 2031 | Key Players Illumina Inc., Natera Inc., Quest Diagnostics, Myriad Genetics, Inc. Centogene, GenPath, PerkinElmer, Yourgene Health, Invitae Corporation, Agilent Technologies, Ario
United States Non Invasive Prenatal Testing (NIPT) Market Size 2023 - 2031 | Key …
The research report on the NIPT Test Market, released by DPI Research, offers a comprehensive analysis of the US industry. The report provides valuable insights into the market's size, share, and industry trends, along with a detailed breakdown of products and services. It presents key statistics regarding the market's status, growth factors, and upcoming trends. The report also discusses the potential industrial opportunities and growth scenarios for the NIPT Test

All 4 Releases


More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the